Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis

Mahmoud Abouraya; James C. Sacco; Brad S. Kahl; Lauren A. Trepanier

首页> 外文期刊>British Journal of Clinical Pharmacology >Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis

【24h】

Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis

机译：预防性甲氧苄氨嘧啶-磺胺甲基异恶唑预防性治疗之前对血液系统恶性肿瘤患者的磺酰胺解毒途径的评估

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT

机译：关于此主题的已知知识

著录项

来源
《British Journal of Clinical Pharmacology》 |2011年第4期|566-574|共9页
作者
Mahmoud Abouraya; James C. Sacco; Brad S. Kahl; Lauren A. Trepanier;
展开▼
作者单位

Department of Medical Sciences School of Veterinary Medicine;

Department of Medicine School of Medicine and Public Health University of Wisconsin-Madison Madison WI USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
co-trimoxazole; drug-specific T cells; leukaemia; lymphoma; myeloma; sulfonamide allergy;

机译：复方新诺明;药物特异性T细胞;白血病;淋巴瘤;骨髓瘤;磺酰胺过敏;
入库时间 2022-08-17 14:09:12

相似文献

外文文献
中文文献
专利

1. Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis. [J] . Abouraya M, Sacco JC, Kahl BS, British Journal of Clinical Pharmacology . 2011,第4期

机译：预防性甲氧苄啶-磺胺甲基异恶唑预防性治疗之前对血液系统恶性肿瘤患者的磺酰胺解毒途径的评估。
2. Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis [J] . Mahmoud Abouraya, James C. Sacco, Brad S. Kahl, British journal of clinical pharmacology . 2011,第4期

机译：在间歇三甲吡啶 - 磺胺甲氧唑预防之前，评价血臭恶性肿瘤患者中的血红胺解毒途径
3. Evaluation of an alternative posaconazole prophylaxis regimen in haematological malignancy patients receiving concomitant stress ulcer prophylaxis [J] . Ross A.L., Slain D., Cumpston A., International journal of antimicrobial agents . 2012,第6期

机译：在接受预防性应激性溃疡的血液系统恶性肿瘤患者中替代泊沙康唑预防方案的评估
4. Evaluating the Process Capability Ratio of Patients' Pathways by the Application of Process Mining, SPC and RTLS [C] . Sina Namaki Araghi, Franck Fontanili, Elyes Lamine, International Joint Conference on Biomedical Engineering Systems and Technologies . 2019

机译：通过应用过程挖掘，SPC和RTLs评估患者途径的过程能力比
5. Clinical and cost outcomes of acyclovir prophylaxis for herpes simplex in leukemia patients: A triangulation of treatment effectiveness evaluation methods [D] . Itzler, Robbin Frances 1998

机译：预防阿昔洛韦在白血病患者中的临床和费用结果：治疗效果评估方法的三角剖分
6. Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis [O] . Mahmoud Abouraya, James C Sacco, Brad S Kahl, 2011

机译：预防性甲氧苄氨嘧啶-磺胺甲基异恶唑预防性治疗之前对血液系统恶性肿瘤患者的磺酰胺解毒途径的评估
7. Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis [O] . Abouraya, Mahmoud, Sacco, James C, Kahl, Brad S, 2011

机译：预防性甲氧苄氨嘧啶-磺胺甲基异恶唑预防性治疗之前对血液系统恶性肿瘤患者的磺酰胺解毒途径的评估

Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis

摘要

著录项

相似文献

相关主题

期刊订阅